Clinical trial
A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs…
NCT00270582 · Far Eastern Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00270582 |
|---|---|
| Title | A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer |
| Official title | A Randomized Phase II Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Far Eastern Memorial Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Taxotere, Cisplatin, Gemcitabine |
| Enrollment | 58 |
| Start date | Nov 1, 2005 |
| First posted | Dec 28, 2005 |
| Last update posted | Feb 9, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: